Capital International LTD Bei Gene, Ltd. Transaction History

Capital International LTD

$2.09 Billion
Q2 2024

A detailed history of Capital International LTD transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Capital International LTD holds 74,692 shares of BGNE stock, worth $15.1 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

74,692

Previous 74,874 0.24%

Holding current value

$15.1 Million

Previous $11.7 Million 8.99%

% of portfolio

0.51%

Previous 0.58%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$129.52 - $174.32 $23,572 - $31,726	-182 Reduced 0.24%	74,692 $10.7 Million
Q1 2024 May 14, 2024	BUY	$141.8 - $181.47 $1.31 Million - $1.67 Million	9,213 Added 14.03%	74,874 $11.7 Million
Q4 2023 Feb 13, 2024	BUY	$158.67 - $201.58 $330,033 - $419,286	2,080 Added 3.27%	65,661 $11.8 Million
Q3 2023 Nov 13, 2023	SELL	$179.87 - $225.13 $71,408 - $89,376	-397 Reduced 0.62%	63,581 $11.4 Million
Q2 2023 Aug 11, 2023	BUY	$178.3 - $266.78 $113,933 - $170,472	639 Added 1.01%	63,978 $11.4 Million
Q1 2023 May 15, 2023	BUY	$215.53 - $274.5 $757,372 - $964,593	3,514 Added 5.87%	63,339 $13.7 Million
Q4 2022 Feb 14, 2023	BUY	$125.51 - $229.3 $603,326 - $1.1 Million	4,807 Added 8.74%	59,825 $13.2 Million
Q3 2022 Nov 14, 2022	BUY	$131.8 - $202.24 $786,977 - $1.21 Million	5,971 Added 12.17%	55,018 $7.42 Million
Q2 2022 Aug 15, 2022	BUY	$121.11 - $216.05 $80,538 - $143,673	665 Added 1.37%	49,047 $7.94 Million
Q4 2021 Feb 14, 2022	BUY	$248.56 - $389.34 $4,474 - $7,008	18 Added 0.04%	48,382 $13.1 Million
Q3 2021 Nov 15, 2021	BUY	$249.6 - $403.14 $464,505 - $750,243	1,861 Added 4.0%	48,364 $17.6 Million
Q2 2021 Aug 16, 2021	SELL	$292.75 - $367.01 $283,674 - $355,632	-969 Reduced 2.04%	46,503 $16 Million
Q1 2021 May 14, 2021	SELL	$260.64 - $382.12 $1.22 Million - $1.79 Million	-4,694 Reduced 9.0%	47,472 $16.5 Million
Q4 2020 Feb 16, 2021	SELL	$221.31 - $316.61 $2.62 Million - $3.74 Million	-11,823 Reduced 18.48%	52,166 $13.5 Million
Q3 2020 Nov 13, 2020	BUY	$189.18 - $286.44 $2.52 Million - $3.81 Million	13,318 Added 26.28%	63,989 $18.3 Million
Q2 2020 Aug 14, 2020	BUY	$123.9 - $195.41 $71,242 - $112,360	575 Added 1.15%	50,671 $9.55 Million
Q1 2020 May 15, 2020	BUY	$121.84 - $173.19 $6.1 Million - $8.68 Million	50,096 New	50,096 $6.17 Million

Others Institutions Holding BGNE

# of Institutions

217

Shares Held

42.1M

Call Options Held

106K

Put Options Held

93.1K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $21B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

News

Stay updated on Capital International LTD with notifications on news.

Account

Capital International LTD Bei Gene, Ltd. Transaction History